Literature DB >> 24173183

Update on therapy for superficial mycoses: review article part I.

Maria Fernanda Reis Gavazzoni Dias1, Maria Victória Pinto Quaresma-Santos, Fred Bernardes-Filho, Adriana Gutstein da Fonseca Amorim, Regina Casz Schechtman, David Rubem Azulay.   

Abstract

Superficial fungal infections of the hair, skin and nails are a major cause of morbidity in the world. Choosing the right treatment is not always simple because of the possibility of drug interactions and side effects. The first part of the article discusses the main treatments for superficial mycoses - keratophytoses, dermatophytosis, candidiasis, with a practical approach to the most commonly-used topical and systemic drugs , referring also to their dosage and duration of use. Promising new, antifungal therapeutic alternatives are also highlighted, as well as available options on the Brazilian and world markets.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24173183      PMCID: PMC3798354          DOI: 10.1590/abd1806-4841.20131996

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  29 in total

Review 1.  Malassezia species in skin diseases.

Authors:  Vicente Crespo Erchiga; Vicente Delgado Florencio
Journal:  Curr Opin Infect Dis       Date:  2002-04       Impact factor: 4.915

Review 2.  Systemic antifungal agents: an update of established and new therapies.

Authors:  Daniel S Loo
Journal:  Adv Dermatol       Date:  2006

Review 3.  Clinical forms of dermatophytosis (ringworm infection).

Authors:  Hugo Degreef
Journal:  Mycopathologia       Date:  2008-05-14       Impact factor: 2.574

4.  The use of high frequency waves to treat onychomycosis: preliminary communication of three cases.

Authors:  Juliana Leal Monteiro da Silva; Gabriela Doimo; Daniele Pedroso Faria
Journal:  An Bras Dermatol       Date:  2011 May-Jun       Impact factor: 1.896

5.  Prognostic factors of mycological cure following treatment of onychomycosis with oral antifungal agents.

Authors:  B Sigurgeirsson; C Paul; D Curran; E G V Evans
Journal:  Br J Dermatol       Date:  2002-12       Impact factor: 9.302

6.  Onychomycosis: a proposed revision of the clinical classification.

Authors:  Roderick J Hay; Robert Baran
Journal:  J Am Acad Dermatol       Date:  2011-04-17       Impact factor: 11.527

7.  Therapeutic options for the treatment of tinea capitis: griseofulvin versus fluconazole.

Authors:  L Dastghaib; M Azizzadeh; P Jafari
Journal:  J Dermatolog Treat       Date:  2005-02       Impact factor: 3.359

8.  Pharmacokinetics of terbinafine in young children treated for tinea capitis.

Authors:  Susan M Abdel-Rahman; Jerry Herron; Sheila Fallon-Friedlander; Suzanne Hauffe; Anne Horowitz; Gilles-Jacques Rivière
Journal:  Pediatr Infect Dis J       Date:  2005-10       Impact factor: 2.129

9.  Nail abrasion.

Authors:  N Di Chiacchio; B V Kadunc; A R T de Almeida; C L Madeira
Journal:  J Cosmet Dermatol       Date:  2003-07       Impact factor: 2.696

Review 10.  Update in antifungal therapy of dermatophytosis.

Authors:  Aditya K Gupta; Elizabeth A Cooper
Journal:  Mycopathologia       Date:  2008-05-14       Impact factor: 2.574

View more
  10 in total

1.  Dermatoscopic findings as a complementary tool in the differential diagnosis of the etiological agent of tinea capitis.

Authors:  Regina Casz Schechtman; Nanashara Diane Valgas Silva; Maria Victória Quaresma; Fred Bernardes Filho; Alice Mota Buçard; Celso Tavares Sodré
Journal:  An Bras Dermatol       Date:  2015 May-Jun       Impact factor: 1.896

2.  Tazarotene as alternative topical treatment for onychomycosis.

Authors:  Elena Campione; Evelin Jasmine Paternò; Gaetana Costanza; Laura Diluvio; Isabella Carboni; Daniele Marino; Cartesio Favalli; Sergio Chimenti; Luca Bianchi; Augusto Orlandi
Journal:  Drug Des Devel Ther       Date:  2015-02-16       Impact factor: 4.162

3.  In vitro activity of econazole in comparison with three common antifungal agents against clinical Candida strains isolated from superficial infections.

Authors:  M Abastabar; T Shokohi; R Rouhi Kord; H Badali; S J Hashemi; Z Ghasemi; A Ghojoghi; N Baghi; M Abdollahi; S Hosseinpoor; N Rahimi; Z Seifi; S Gholami; I Haghani; M R Jabari; A Pagheh
Journal:  Curr Med Mycol       Date:  2015-12

4.  Antidermatophytic Activity of the Fruticose Lichen Usnea orientalis.

Authors:  Ashutosh Pathak; Dalip Kumar Upreti; Anupam Dikshit
Journal:  Medicines (Basel)       Date:  2016-09-12

5.  Prevalence of dermatoses in patients referred for evaluation in an outpatient clinic of specialties.

Authors:  João Avancini; Paola Zucchi
Journal:  An Bras Dermatol       Date:  2018 Jul-Aug       Impact factor: 1.896

6.  Tinea nigra palmaris: a clinical case in a rural Ethiopian hospital.

Authors:  Ramón Perez-Tanoira; Carlos Zarco Olivo; José Fortes Alen; Laura Prieto-Pérez; Alfonso Cabello; Jose Manuel Ramos Rincón; Juan Cuadros; Miguel Górgolas
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2018-09-13       Impact factor: 1.846

7.  Identification of Dermatophyte and Nondermatophyte Molds Isolated from Animal Lesions Suspected to Dermatomycoses.

Authors:  Tahereh Rahimi; Rasoul Mohammadi
Journal:  Adv Biomed Res       Date:  2020-01-21

8.  Image-Processing Scheme to Detect Superficial Fungal Infections of the Skin.

Authors:  Ulf Mäder; Niko Quiskamp; Sören Wildenhain; Thomas Schmidts; Peter Mayser; Frank Runkel; Martin Fiebich
Journal:  Comput Math Methods Med       Date:  2015-11-16       Impact factor: 2.238

9.  Metal Chelation as a Powerful Strategy to Probe Cellular Circuitry Governing Fungal Drug Resistance and Morphogenesis.

Authors:  Elizabeth J Polvi; Anna F Averette; Soo Chan Lee; Taeyup Kim; Yong-Sun Bahn; Amanda O Veri; Nicole Robbins; Joseph Heitman; Leah E Cowen
Journal:  PLoS Genet       Date:  2016-10-03       Impact factor: 5.917

10.  Do Antimicrobial Proteins Contribute to Overcoming the Hidden Antifungal Crisis at the Dawn of a Post-Antibiotic Era?

Authors:  László Galgóczy; Florentine Marx
Journal:  Microorganisms       Date:  2019-01-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.